PROSTATE SPECIFIC ANTIGEN CONTROL— 510(k) K973099

Name: FDA 510(k) clearance K973099
Creator: U.S. Food and Drug Administration
Published: 1997-09-29

Substantially Equivalent

Dade Chemistry Systems, Inc.

FDA 510(k) clearance K973099 for PROSTATE SPECIFIC ANTIGEN CONTROL, Substantially Equivalent on 1997-09-29. Applicant: Dade Chemistry Systems, Inc.. Device class: 1.

Clearance details

Applicant: Dade Chemistry Systems, Inc.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1997-08-19
Decision date: 1997-09-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Dade Chemistry Systems, Inc.

view all

K973650 — TROPONIN (TROP) METHOD1997-10-20
K973100 — PROSTATE SPECIFIC ANTIGEN (PSA) CALIBRATOR1997-09-29
K973101 — PROSTATE SPECIFIC ANTIGEN METHOD1997-09-18
K971141 — FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM1997-04-28
K970387 — HUMAN CHORIONIC GONADOTROPIN METHOD1997-03-10

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.